Stakeholder Engagement in a Patient-Reported Outcomes (PRO) Measure Implementation: A Report from the SAFTINet Practice-based Research Network (PBRN).

Kwan BM1, Sills MR2, Graham D2, Hamer MK2, Fairclough DL2, Hammermeister KE2, Kaiser A2, de Jesus Diaz-Perez M2, Schilling LM2.

Author information

Abstract

PURPOSE:

Patient-reported outcome (PRO) measures offer value for clinicians and researchers, although priorities and value propositions can conflict. PRO implementation in clinical practice may benefit from stakeholder engagement methods to align research and clinical practicestakeholder perspectives. The objective is to demonstrate the use of stakeholder engagement in PRO implementation.

METHOD:

Engaged stakeholders represented researchers and clinical practice representatives from the SAFTINet practice-based research network(PBRN). A stakeholder engagement process involving iterative analysis, deliberation, and decision making guided implementation of a medication adherence PRO measure (the Medication Adherence Survey [MAS]) for patients with hypertension and/or hyperlipidemia.

RESULTS:

Over 9 months, 40 of 45 practices (89%) implemented the MAS, collecting 3,247 surveys (mean = 72, median = 30, range: 0 - 416). Facilitators included: an electronic health record (EHR) with readily modifiable templates; existing staff, tools and workflows in which the MAS could be integrated (e.g., health risk appraisals, hypertension-specific visits, care coordinators); and engaged leadership and quality improvement teams.

CONCLUSION:

Stakeholder engagement appeared useful for promoting PRO measure implementation in clinical practice, in a way that met the needs of both researchers and clinical practice stakeholders. Limitations of this approach and opportunities for improving the PRO data collection infrastructure in PBRNs are discussed.

KEYWORDS:

Comparative Effectiveness Research; Hypertension; Medication Adherence; Patient Outcome Assessment; Patient-centered OutcomesResearch; Practice-based Research